Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.

Hedy L Kindler; Gregory Friberg; Deepti A Singh; Gershon Locker; Sreenivasa Nattam; Mark Kozloff; David A Taber; Theodore Karrison; Abraham Dachman; Walter M Stadler

doi:10.1200/JCO.2005.01.9661

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.

Identifier:nobleid.org/w1/20260515/06EBDCD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/06EBDCD3.svg?ark=w1%2F20260515%2F06EBDCD3)](https://nobleid.org/work/w1/20260515/06EBDCD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.

Identifier:nobleid.org/w1/20260515/06EBDCD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/06EBDCD3.svg?ark=w1%2F20260515%2F06EBDCD3)](https://nobleid.org/work/w1/20260515/06EBDCD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work